Akela Pharma Inc. AKLPF

AKELA PHARMA INC.

[modulex]

December 9, 2012

Mrs. Livia Legault CA
Registered Office and Head Office of TMX Group
The Exchange Tower
130 King Street West
Toronto, ON
M5X 1J2

Madam,

I regret to inform you that your December 3, 2012 reply concerning Akela Pharma Inc. is sheer nonsense.

You are invoking on the one hand, that TSX relies upon interested parties to bring to our attention, concerns that might well be concerns to all shareholders of a listed issuer and, on the other hand, that the results of an investigation, if any is undertaken, must and do remain confidential and will be discussed in confidence with the issuer. How cynical and irrespectful are you of shareholders to say these stupid remarks. How can you pretend the TSX to be at help to shareholders when you shut them the door under the shield of confidentiality with the listed issuer. It is absurd.

You should at least be logical with yourself, on behalf of the TSX, and say frankly and openly that the TSX is unable to provide any assistance to shareholders beyond any issue related, for instance, to stock trading regulations instead of treating Akela Pharma Inc. shareholders hypocritically.

Akela Pharma Inc. shareholders are currently subject to a situation of "breach of trust" from management, in the sense that they are unaware of what lies ahead for them following their shares delisting. The company has not duly informed them, via an appropriate channel, which is the company's website WWW.AKELAPHARMAINC. of the said shares delisting, the moving of headquarters from the State of Texas to the State of California, at what address the company is moving to in the State of California, why does it still uses contact phone numbers in the State of Texas if it pretends having moved to the State of California and other issues of consideration. Mr. Rudy J. Emmelot, President and Chief Executive of Akela Pharma Inc. is unwilling to answer shareholders' concerns addressed in my November 30, 2012 e-mail herebelow. All this, demonstrating that management of Akela Pharma Inc. is not fulfilling its obligations of accountability with shareholders of a public company. And this is clearly a matter of BREACH OF TRUST.

If you can't be alerted and understanding of such important shareholders' concerns, then you have a severe problem of integrity within your occupational role at the TSX, which requires an investigation.

Luc Proulx

[e-mail]

Akela Pharma Inc. shareholder

c.c. Thomas A. Kloet, Chief Executive Officer, TMX Group
_______________________________________________________________________________________________________________


Reply of Mr. Rudy J. Emmelot - December 1, 2012

HelloLuc,

Thank you for your inquiry. Please reference Akela’s official filings and notices at www.SEDAR.com.

Also for your reference, I have included several public and official press releases from the Company and various regulatory agencies for your reference.

_______________________________________________________________________________________

From: [e-mail]
To: [e-mail]
Subject: RE: AKELA PHARMA INC.
Date: Mon, 3 Dec 2012 15:45:46 +0000

Hello Mr. Proulx,

Thank you for your email. TSX relies upon interested parties to bring to our attention, concerns that might well be concerns to all shareholders of a listed issuer.

Please note, that the results of an investigation, if any is undertaken, must and do remain confidential and will be discussed in confidence with the Issuer, if necessary.

The halt notice discloses that the stock was halted due to a Cease Trade Order (CTO). You can contact the Company or its principal regulator, British Columbia Securities Commission, for details on the CTO.

If you have any questions, feel free to contact me.

Regards,

Livia Legault, CA

416-947-4250

December 1, 2012

Registered Office and Head Office of TMX Group
The Exchange Tower
130 King Street West
Toronto, ON
M5X 1J2


RE: AKELA PHARMA INC. (AKL-Toronto Stock Exchange)
___________________________________________________________

To Whom it may Concern:

I am noticing that the above-noted company has been halted from trading as of November 23, 2012, without notification to its shareholders.

I have attempted on November 30, 2012 to contact management for a follow-up on this matter, having yet received no reply.

The company is also reported having moved its headquarters from the State of Texas to the State of California, again without updating its shareholders.

The company's stock has traded on relatively high volumes in the past three months, in a downward trend, to close at $0.01 on the day prior to its halting.

It is obviously clear that the company is neglectful to its shareholders by "running away and hiding".

I would therefore like to know from the TMX Group the reason(s) that prompted the stock to be halted on November 23, 2012 and what recourse(s) is/are available to shareholders.

Does the TMX Group or perhaps the Ontario Securities Commission or IIROC (Investment Industry Regulatory Organization of Canada) have any input/scope of intervention to bring the company to explain itself as to why it behaved inappropriately and take punitive actions against the company?